Vaccine may delay recurrence for advanced ovarian cancers
the ONA take:
According to preliminary findings presented at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer in Chicago, Illinois, researchers have found that a vaccine delayed cancer recurrence in women with stage III or IV ovarian cancers.
For the phase II study, researchers enrolled 31 women with stage III or IV ovarian cancer. Of those, 20 received the experimental immunotherapy and 11 did not. Results showed that those who did not receive the immunotherapy experienced a cancer recurrence in a median of 14.5 months, while those who did receive the vaccine have not yet reached the median time to recurrence. Thus far, the majority of the study population is beyond the 14.5 months.
"This was a preliminary study with promising results that may give women with advanced ovarian cancer an option for a maintenance regimen," said Jonathan Oh, MD, a gynecologic oncologist at Texas Oncology, P.A., in Dallas, Texas. "Additionally, the vaccine is very well tolerated."
The findings suggest that using a patient's own immune system to combat advanced ovarian cancer may be promising strategy to improve patient outcomes.
Researchers have found that a vaccine delayed cancer recurrence in women with stage III or IV ovarian cancers.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Coping With Lymphedema: A Patient Guide (Fact Sheet)
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|